NCT04510766Recrutement en cours
Tumor Molecular Profiling in Early Phase Clinical Trials
Résumé
Prospective, single centre, non-interventional exploratory research project that will be conducted on biological material and health-related personal data collected.
Critères d'inclusion
1. Male or female patients age at least 18 years. 2. Patients with histological diagnosis of advanced solid tumor or lymphoma who are potential candidates for early phase clinical trials. 3. Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1 4. Live expectancy of at least 6 months. 5. Availability of FFPE archival tumor tissue from previous surgery or diagnostic biopsy adequate for molecular analysis. 6. Ability to understand the patient information and study consent. Signed and dated written informed consent must be available before performing any study-related procedure. 7. Willing and able to comply with study procedures
Critères d'exclusion
1. Presence of any clinical (e.g. concomitant disease, clinically significant symptoms, or non-clinical (psychological or social) conditions that would not make the patient eligible for enrolment in an early phase clinical trial. 2. Any other active malignancy (other than the one for which the subject is being assessed for trial option) that is progressing or requiring active treatment with the exception of basal or squamous cell skin cancer, superficial bladder cancer, carcinoma in situ of any site.
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- —
- Type d'étude
- Observationnelle
- Pays
- Suisse
- Promoteur
- Oncology Institute of Southern Switzerland(Autre)
- N° de protocole
- IOSI-USNF-001
- Pathologies
- Advanced Solid Tumor, Lymphoma
- Interventions
- —
Collaborateurs
Ente Ospedaliero Cantonale, Bellinzona, Istituto Cantonale di Patologia
Lieux · 1
- Bellinzona, SuisseOncology Institute of Southern SwitzerlandRecrute dans ce centre
Au total, dans le monde, le seul centre listé au registre recrute.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 18 novembre 2025).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.